News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Ainsworth Sean
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/08/2023 |
4
| Ainsworth Sean (Director) has filed a Form 4 on Ocuphire Pharma, Inc.
Txns:
| Granted 10,976 shares
@ $0 Granted 9,639 options
@ $3.83, valued at
$36.9k
|
|
10/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/25/2020 |
4
| Ainsworth Sean (Director) has filed a Form 4 on Ocuphire Pharma, Inc.
Txns:
| Bought 8,865 shares
@ $0 Bought 13,394 options to buy
@ $0 Bought 1,574 options to buy
@ $0.0001, valued at
$0.2 |
|
11/13/2020 |
4
| Ainsworth Sean (Director) has filed a Form 4 on Ocuphire Pharma, Inc.
Txns:
| Granted 5,000 options to buy
@ $4.05, valued at
$20.3k
|
|
11/09/2020 |
4
| Ainsworth Sean (Director) has filed a Form 4 on Ocuphire Pharma, Inc.
Txns:
| Granted 35,800 shares
@ $0 Granted 35,663 options to buy
@ $0.9, valued at
$32.1k
Granted 52,825 options to buy
@ $1.21, valued at
$63.9k
|
|
11/09/2020 |
3
| Ainsworth Sean (Director) has filed a Form 3 on REXAHN PHARMACEUTICALS, INC. |
|
|